Overexpression of EGFR and inhibition of proliferation has been observed in cisplatin-treated ovarian carcinoma cells, and these molecular changes were hypothesized to be an escape mechanism of tumor cells [39]. The gene discussed is EGFR; the disease is ovarian carcinoma.